Initial FDG-PET/CT predicts survival in adults Ewing sarcoma family of tumors.
Purpose
The aim of this retrospective study was to determine, at baseline, the prognostic value of different FDG-PET/CT quantitative parameters in a homogenous Ewing Sarcoma Family of Tumors (ESFT) adult population, compared with clinically relevant prognostic factors.


Methods
Adult patients from 3 oncological centers, all with proved ESFT, were retrospectively included. Quantitative FDG-PET/CT parameters (SUV (maximum, peak and mean), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) of the primary lesion of each patient were recorded before treatment, as well as usual clinical prognostic factors (stage of disease, location, tumor size, gender and age). Then, their relation with progression free survival (PFS) and overall survival (OS) was evaluated.


Results
32 patients were included. Median age was 21 years (range, 15 to 61). Nineteen patients (59%) were initially metastatic. On multivariate analysis, high SUVmax remained independent predictor of worst OS (p=0.02) and PFS (p=0.019), metastatic disease of worst PFS (p=0.01) and high SUVpeak of worst OS (p=0.01). Optimal prognostic cut-off of SUVpeak was found at 12.5 in multivariate analyses for PFS and OS (p=0.0001).


Conclusions
FDG-PET/CT, recommended at ESFT diagnosis for initial staging, can be a useful tool for predicting long-term adult patients outcome through semi-quantitative parameters.
['Jamet|Bastien|B|', 'Carlier|Thomas|T|', 'Campion|Loic|L|', 'Bompas|Emmanuelle|E|', 'Girault|Sylvie|S|', 'Borrely|Fanny|F|', 'Ferrer|Ludovic|L|', 'Rousseau|Maxime|M|', 'Venel|Yann|Y|', 'Kraeber-Bodéré|Françoise|F|', 'Rousseau|Caroline|C|']
FDG-PET/CT Ewing sarcoma family of tumors oncology prognosis survival analysis